Clinical Trials Browser

Terminated × Neoplasms × Rifampin × Clear all

NCT02875223 2025-04-20

A Safety and Efficacy Study of CC-90011 in Participants With Relapsed and/or Refractory Solid Tumors and Non-Hodgkin's Lymphomas

Phase 1 Terminated

75 enrolled 35 charts

Lymphoma, Non-Hodgkin, Neoplasms